The meaning of clinical remission in polyarticular juvenile idiopathic arthritis: gene expression profiling in peripheral blood mononuclear cells identifies distinct disease states
about
Network analysis and juvenile idiopathic arthritis (JIA): a new horizon for the understanding of disease pathogenesis and therapeutic target identificationDevelopment of biomarkers to optimize pediatric patient management: what makes children different?Genomic characterization of remission in juvenile idiopathic arthritis.Cell subset prediction for blood genomic studiesWhole-Genome Sequencing and Integrative Genomic Analysis Approach on Two 22q11.2 Deletion Syndrome Family Trios for Genotype to Phenotype Correlations.Dynamic tracking of functional gene modules in treated juvenile idiopathic arthritis.Whole blood expression profiling from the TREAT trial: insights for the pathogenesis of polyarticular juvenile idiopathic arthritisSystems biology coupled with label-free high-throughput detection as a novel approach for diagnosis of chronic obstructive pulmonary disease.Current developments in the use of biomarkers for juvenile idiopathic arthritis.Chromatin landscapes and genetic risk for juvenile idiopathic arthritis.Transcriptional profiling to identify biomarkers of disease and drug response.Gene expression profiling in neutrophils from children with polyarticular juvenile idiopathic arthritis.Increased baseline RUNX2, caspase 3 and p21 gene expressions in the peripheral blood of disease-modifying anti-rheumatic drug-naïve rheumatoid arthritis patients are associated with improved clinical response to methotrexate therapy.American College of Rheumatology provisional criteria for defining clinical inactive disease in select categories of juvenile idiopathic arthritis.Quantitative Validation and Comparison of Multiplex Cytokine KitsOngoing disease activity and changing categories in a long-term nordic cohort study of juvenile idiopathic arthritis
P2860
Q26740527-0A1236DC-37A3-4CFF-AF2B-69AA39C6B4DDQ26822946-8B3DF240-0993-469B-AFD1-05D8796CDC74Q33775236-096A4357-599E-482C-99C7-3F267C39C379Q33942400-2BCCD5AB-0D9B-4CCB-BA19-200AF95695C6Q35888105-B17B76BC-BE2D-43DE-B1B5-6ECF5CE1CA6BQ36203332-3B9C6C64-1FF4-43F6-9858-D4BD21ECBC7DQ37073220-8DD5DF3B-87BE-4ABD-9F3B-D1FA79895AA0Q37182109-B0DAB3B2-C3EA-4209-8E33-8FA56F8AEF10Q37595918-14B4994D-9007-4347-9B8B-BB183C0CE13FQ37697949-2050C6C3-8E19-49A9-A742-FA04FB841D1DQ37844547-09683115-C60E-4BD0-969D-411B4886F31AQ41836488-19706493-2E57-49D3-820F-C14038A4F4E6Q48030951-183D3605-95FA-4B8C-A4DB-71D028F85E90Q53150640-AF2B4E6C-415B-4309-B45C-B5AA7098888AQ57203286-EA74BD18-898C-4ECA-95BC-9E778C82B7A3Q58069239-CA521309-B2A5-46A8-9F8A-BE70687DF824
P2860
The meaning of clinical remission in polyarticular juvenile idiopathic arthritis: gene expression profiling in peripheral blood mononuclear cells identifies distinct disease states
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The meaning of clinical remiss ...... tifies distinct disease states
@en
The meaning of clinical remiss ...... ifies distinct disease states.
@nl
type
label
The meaning of clinical remiss ...... tifies distinct disease states
@en
The meaning of clinical remiss ...... ifies distinct disease states.
@nl
prefLabel
The meaning of clinical remiss ...... tifies distinct disease states
@en
The meaning of clinical remiss ...... ifies distinct disease states.
@nl
P2093
P2860
P356
P1476
The meaning of clinical remiss ...... tifies distinct disease states
@en
P2093
Amita Aggarwal
Brad Chaser
Carol Wallace
Catherine Tung
James N Jarvis
Jeanette Osban
Julie L McGhee
Kaiyu Jiang
Kathleen O'Neil
Laura Smith
P2860
P304
P356
10.1002/ART.24298
P577
2009-03-01T00:00:00Z